ET-1- and NO-mediated signal transduction pathway in human brain capillary endothelial cells

American Journal of Physiology - Cell Physiology

Volumn 284, Issue 2 53-2, 2003, Pages

  Chen, Y ^a   McCarron, R M ^b   Golech, S ^b   Bembry, J ^a   Ford, B ^c   Lenz, F A ^d   Azzam, N ^a   Spatz, M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium mobilization; Capillary endothelium; Cytoskeleton; Endothelin 1; Nitric oxide

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; CALCIUM ION; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ENDOTHELIN 1; GUANYLATE CYCLASE INHIBITOR; MASTOPARAN; NITRIC OXIDE; VASOACTIVE AGENT;

BLOOD BRAIN BARRIER; BLOOD VESSEL TONE; BRAIN CAPILLARY; CALCIUM MOBILIZATION; CAPILLARY ENDOTHELIUM; CYTOSKELETON; DOSE RESPONSE; HUMAN; HUMAN CELL; MICROCIRCULATION; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037304106     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00305.2002     Document Type: Review

References (42)

1. Bacic F, Uematsu S, McCarron RM, and Spatz M. Secretion of immunoreactive endothelin-1 by capillary and microvascular endothelin of human brain. Neurochem Res 17: 699-702, 1992.
2. Boulanger C and Luscher T. Release of endothelin from the porcine aorta: inhibition by endothelin-derived nitric oxide. J Clin Invest 85: 587-590, 1990.
3. 2+ mobilization and cytoskeletal F-actin filaments in human cerebromicrovascular endothelial cells. J Cereb Blood Flow Metab 19: 133-138, 1999.
4. Chen Y, McCarron RM, Ohara Y, Bembry J, Azzam N, Lenz FA, Shohami E, Mechoulam R, and Spatz M. Human brain capillary endothelium 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ Res 87: 323-327, 2000.
5. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, and Colgan SP. Role of vasodilator-stimulated phosphoprotein in protein kinase A-induced changes in endothelial junctional permeability. FASEB J 16: 583-585, 2002.
6. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem 264: 1146-1155, 1989.
7. Draijer R, Vaandrager AB, Nolte C, de Jonge H, Walter U, and Hindsbergh VWM. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate VASP in human endothelial cells of different origin. Circ Res 77: 897-905, 1995.
8. Dudek SM and Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487-1500, 2001.
9. Durieu-Trautmann O, Federici C, Creminon C, Foignant-Chaverot N, Roux F, Claire M, Strosberg AD, and Couraud PO. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J Cell Physiol 155: 104-111, 1993.
10. Faraci FM and Sobey CG. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation. Brain Res 821: 368-373, 1999.
11. Farre AL, Riesco A, Moliz M, Egido J, Casado S, Hernando L, and Caramelo C. Inhibition by L-arginine of the endothelin-mediated increase in cytosolic calcium in human neutrophils. Biochem Biophys Res Commun 178: 884-891, 1991.
12. Gellai M, De Wolf R, Fletcher T, and Nambi P. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of the nitric oxide. Pharmacology 55: 299-308, 1997.
13. Goligorsky MA, Tsukahara H, Magazine H, Andersen TT, Malik AB, and Bahou WF. Termination of endothelin signaling: role of nitric oxide. J Cell Physiol 158: 485-494, 1994.
14. Harbeck B, Huttelmaier S, Schluter K, Jockusch BM, and Illenberger S. Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin. J Biol Chem 275: 30817-30825, 2000.
15. Haynes WG and Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 16: 1081-1098, 1998.
16. Iadecola C, Pelligrino DA, Moskowitz MA, and Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14: 175-192, 1994.
17. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, and Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863-2867, 1989.
18. Kawanabe Y, Okamoto Y, Nozaki K, Hashimoto N, Miwa S, and Masaki T. Molecular mechanism for endothelin-1-induced stress-fiber formation: analysis of G proteins using a mutant endothelin(A) receptor. Mol Pharmacol 61: 277-284, 2002.
19. Lavalle M, Takamura M, Parent R, and Thorin E. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev 6: 265-276, 2001.
20. MacCumber MW, Ross AC, and Snyder SH. Endothelin in the brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci USA 87: 2359-2363, 1990.
21. MacMillan-Crow LA and Lincoln TM. High-affinity binding and localization of the cyclic GMP-dependent protein kinase with the intermediate filament protein vimentin. Biochemistry 33:8035-8043, 1994.
22. Masaki T. Endothelin in vascular biology. Ann NY Acad Sci 714: 101-108, 1994.
23. Mayhan WG. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 866: 101-108, 2000.
24. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
25. Montanari A, Biggi A, Carra N, Fasoli E, Calzolari M, Corsini F, Perinotto, and Novarini A. Endothelin-A blockade attenuates systemic and renal hemodynamic effects of L-NAME in humans. Hypertension 35: 518-523, 2000.
26. 2+ mobilization in rat vascular smooth muscle cells. Biochem Biophys Res Commun 183: 849-855, 1992.
27. Pryzwansky KB, Wyatt TA, and Lincoln TM. Cyclic guanosine monophosphate-dependent protein kinase is targeted to intermediate filaments and phosphorylates vimentin in A23187-stimulated human neutrophils. Blood 85: 222-230, 1995.
28. Rapport SI. Blood-Brain Barrier in Physiology and Medicine. New York: Raven, 1976.
29. Rasmussen H. Cellular calcium metabolism. Ann Intern Med 98: 809-816, 1983.
30. Reinhard M, Giehl K, Abel K, Haffner C, Jarchau T, Hoppe V, Jockusch BM, and Walter U. The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J 14: 1583-1589, 1995.
31. Reinhard M, Halbrugge M, Scheer U, Wiegand C, Jockusch BM, and Walter U. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J 11: 2063-2070, 1992.
32. Rubanyi GM and Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 46: 325-415, 1994.
33. Saijonmaa O, Ristimaki A, and Fyhrquist F. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun 173: 514-520, 1990.
34. Shyamaladevi N, Jayakumar AR, Sujatha R, Paul V, and Subramanian EH. Evidence that nitric oxide production increases gamma-amino butyric acid permeability of blood-brain barrier. Brain Res Bull 57: 231-236, 2002.
35. Spatz M, Kawai N, Merkel N, Bembry J, and McCarron RM. Functional properties of cultured endothelial cells derived from large microvessels of human brain. Am J Physiol Cell Physiol 272: C231-C239, 1997.
36. Spatz M, Stanimirovic D, and McCarron RM. Endothelin as a mediator of blood-brain barrier function. In: New Concepts of a Blood-Brain Barrier, edited by Greenwood J, Begley DJ, and Segal MB. New York: Plenum, 1995, p. 47-61.
37. Spatz M, Yamamoto H, Yamamoto T, and McCarron RM. Effect of nitric oxide donors on ET-1 binding sites in human cerebrovascular endothelium (Abstract). J Cereb Blood Flow Metab 17, Suppl 1: S397, 1997.
38. A receptors. Brain Res 726: 242-246, 1996.
39. Stanimirovic D, Yamamoto T, Uematsu S, and Spatz M. Endothelin-1 receptor binding and cellular signal transduction in cultured human brain endothelial cells. J Neurochem 62: 592-901, 1994.
40. Van Hinsbergh VW and van Amerongen GP. Intracellular signalling involved in modulating human endothelial barrier function. J Anat 200: 549-560, 2002.
41. Wiley KE and Davenport AP. Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol 132: 213-220, 2001.
42. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictive peptide produced by endothelial cells. Nature 332: 411-415, 1988.